New Jersey Heart — Linden, New Jersey

New Jersey Heart is a clinical research site located in Linden, New Jersey, United States 07036.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

New Jersey Heart has participated in 7 clinical trials with 2 currently active.

Therapeutic areas: Primary Prevention of Atherosclerotic Cardiovascular Disease, Diabetes Mellitus, Type 2, Cardiovascular Diseases.

Sponsors: Novartis Pharmaceuticals, Duke University, Brigham and Women's Hospital.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New Jersey Heart?

New Jersey Heart has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New Jersey Heart conducted?

New Jersey Heart has 7 clinical trials on record, with 2 currently active. Their work covers Primary Prevention of Atherosclerotic Cardiovascular Disease, Diabetes Mellitus, Type 2, Cardiovascular Diseases.

Is New Jersey Heart accredited by Crixeo Health?

Yes — New Jersey Heart holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about New Jersey Heart?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.